The effect of procainamide and digoxin, singly and together, on peak active force and rate of force development of isolated right ventricular papillary muscles from adult cats was examined. Procainamide (1.5 x 1O-5M) increased force and rate of force development in each muscle with further increments in performance up to 2.4 x 1O-4 M in most muscles. The maximal increases in force (± SEM) averaged 75 ± 13% above control values. Essentially no response to procainamide was observed when basal levels of contractile state were Increased by increasing stimulus frequency or calcium concentrations of the bathing solution. Propranolol (10-6M) markedly reduced and verapamil (I0 -7M) abolished the Recently, we reported (I) that quinidine in concentrations that are therapeutic in human patients had a variable inotropic effect, but significantly inhibited the positive inotropic action of digoxin in vitro . Procainamide and disopyramide are grouped with quinidine as class I antiarrhythmic agent s, yet it is well recognized that there are significant differences among these drugs in their hemodynamic effects (2-4) as well as their effect on serum digoxin levels (5). It is generally accepted that disopyramide possesses negative inotropic effects (4), but the effect of procainamide on myocardial mechanical performance remain s in question (2 ,3 ,6-9). Furthermore, to our knowledge there is no informat ion as to the effect of these latter agents on digitalis inotropy . Accordingly , we examined the myocardial contractile effects of procainamide and digoxin, singly and in combination, using the method s we employed previously in our quinidine-digoxin study (I ).
The effect of procainamide and digoxin, singly and together, on peak active force and rate of force development of isolated right ventricular papillary muscles from adult cats was examined. Procainamide (1.5 x 1O-5M) increased force and rate of force development in each muscle with further increments in performance up to 2.4 x 1O-4 M in most muscles. The maximal increases in force (± SEM) averaged 75 ± 13% above control values. Essentially no response to procainamide was observed when basal levels of contractile state were Increased by increasing stimulus frequency or calcium concentrations of the bathing solution. Propranolol (10-6M) markedly reduced and verapamil (I0 -7M) abolished the Recently, we reported (I) that quinidine in concentrations that are therapeutic in human patients had a variable inotropic effect, but significantly inhibited the positive inotropic action of digoxin in vitro . Procainamide and disopyramide are grouped with quinidine as class I antiarrhythmic agent s, yet it is well recognized that there are significant differences among these drugs in their hemodynamic effects (2) (3) (4) as well as their effect on serum digoxin levels (5) . It is generally accepted that disopyramide possesses negative inotropic effects (4) , but the effect of procainamide on myocardial mechanical performance remain s in question (2 ,3 ,6-9) . Furthermore, to our knowledge there is no informat ion as to the effect of these latter agents on digitalis inotropy . Accordingly , we examined the myocardial contractile effects of procainamide and digoxin, singly and in combination, using the method s we employed previously in our quinidine-digoxin study (I ) .
inotropic effect of procalnamide, Exposing muscles to procainamide (1.5 or 3 x IO-sM) before or after the administration of digoxin (2 or 4 x 10-7M) did not alter the inotropic action of either drug.
Thus, procainamide in concentrations that are in the therapeutic range in human patients has potent positive inotropic effects that may be masked at high levels of contractile state. This action of procainamide appears to be due to an effect on calcium channels, which in part may be due to beta-adrenergic receptor stimulation. These concentrations of procainaritide do not alter the inotropic response to digoxin.
Methods
Preparation of papillary muscles. Right ventricular papillary muscles were removed from anesthetized adult cats and placed immediately in a muscle bath containing a solution of the following cqncentration (roM): sodium 143, potassium 4.5, magnesium 0.5 , calcium 1.25, chlorine 124, H zP04 -1.2, HC0 3 24 and glucose 5.6. The solution was bubbled vigorously with 95% oxygen and 5% carbon dioxide , which produced a (Po-) partial pressure of oxygen of greater than 500 mm Hg and a pH of 7.4. Temperature was maintained at 30 DC and the muscle was stimulated at a frequency of 12/min using field electrodes parallel to the long axis of the muscle . Stimulu s voltage was maintained at 10% above threshold values and was checked frequentl y during each experiment. The nontendinous end of the muscle was held by a clip that was secured to the bottom of the bath . The tendinous end was attached by a short silk suture to a force transducer. The transducer was fixed to a micrometer that permitted muscle length to be altered by known amounts while the muscle contracted isometrically .
The muscle was stretched to 0.5 g of resting tension and allowed to contract isometrically for 45 to 60 minute s, at which time contractile force was stable . The muscle was then stretched slowly until peak active force was obtained. Muscle length was fixed at this point and peak active force 0735-1097/84 /$3.00 and the maximal rate of force development (dF/dt) were recorded, the latter determined electronically.
Studies with precainamide and digoxin. Muscles from nine cats were exposed to increasing concentrations of procainamide ranging from 1.5 x 10-5 to 2.4 x 1O-4M.
After each increment in concentration, adequate time was allowed for contractile force to become stable before the concentration was increased further. Seven additional muscles were exposed to 1.5 x 10 -5M and another seven muscles were exposed to 3 x 1O-5M procainamide, after which each group was exposed to 2 x 1O-7M digoxin. After these observations were made, the concentration of digoxin was increased to 4 x 10-7M in those muscles exposed initially to 3 >: 1O-5M procainamide. Thirteen muscles were exposed to digoxin alone initially at a concentration of 2 x 10 7M, which subsequently was increased to 4 x IO-7M. Five additional muscles were exposed initially to 4 x 10-7M digoxin, followed by increasing concentrations of procainamide. We selected these digoxin concentrations on the basis of our earlier observation that 2 < 1O- 7M digoxin produced approximately half the maximal inotropic effect obtainable with the glycoside, where as 4 x 10-7M digoxin produced a near maximal effect.
Procainamide studies after propranolol or verapamil. After our observations on the effect of procainamide alone, we exposed six muscles to lO-6M propranolol and then to increasing concentrations of procainamide, We also exposed nine muscles to lO-7M verapamil, followed by increasing concentrations of procainamide.
Procainamide studies at higher stimulus frequency and calcium concentration. In five other muscles, the frequency of stimulation was increased from 12 to 30/min, after which the muscles were exposed to increasing concentrations of procainamide. In seven muscles, the calcium roM, and the studies with procainamide alone were repeated.
Procainamide was dissolved in distilled water. The muscle bath contained 30 ml of modified Krebs solutions, and the largest volume of procainamide-containing solution added during any experiment was 1.28 ml.
Developed force and dF/dt were normalized for differences in muscle size by expressing these variables in units per cross-sectional area. Cross-sectional area of the muscle was determined from its weight wet and length at peak active force development as measured with a calibrated reticle.
Statistical calculations. Statistical analyses were performed using Student's paired and unpaired t test when comparing respective values in individual animals or between groups, respectively. Analysis of variance was used when comparing values among groups (10) .
Results
Cross-sectional area of the muscles (mean ± standard error of the mean) in the various groups averaged 1.2 ± 0.1 mm? (range 0.94 to 1.3). Differences among groups were not statistically significant.
In all studies, changes in rate of force development were quantitatively similar to the changes in developed force. Therefore, We elected to present only the developed force data.
Procainamide effect. The effect of increasing concentrations of procainamide on contractile force is given in Table I Group A in = 9) g/rnrrr'
1.9 ± 0.4 2.5 ± 0.5 2.6* ± 0.5 2.9* ± 0.5 3.1* ± 0.5 2.9* ± 0.5 % control 125 ± 4.3 142 ± 6.7 162 ± 10.5 175 ± 13.0 167 ± 14.0 Group B (n = 5) g/rnrrr'
3.1 ± 0. g/mrn 4.6 ± 0.7 4.9 ± 0.7 5.0 ± 0.7 5.1 ± 0.6 5.1 ± 0.6 5.1 ± 0.7 % control 109 ± 0.8 112 ± 2.5 113 ± 3.2 114 ± 2.6 113 ± 3.9 Group D in = 5) g/mm 2.5 ± 0.6 3.2* ± 0.7 3.8* ± 0. Procainamlde effect with increased calcium concentration. Doubling the concentration of calcium in the bathing solution to 2 .5 roM before the addition of procainamide resulted in a marked increase in active force development (Table I) . Under these conditions, addition of procainamide resulted in no significant increment in mechanical performance , Procainamide effect at higher stimulus frequency.
Increasing stimulus frequency froin 12 to 30/min increased developed force by an average of 57 ± 13%. Procainamide then produced no increase in force (Table I) .
Procainamide effect after propranolol or verapamil. The positive inotropic effect of each concentration of procainamide was significantly less after pretreatment with 1O-6M propranolol and was abolished by pretreatment with 1O -7M verapamil (Fig. I ).
Procainamide-digoxin interaction. The effect of 2 x 10-7 and 4 x 1O- 7 M digoxin alone and after 1.5 X 10-5 and 3 x 1O -5M procainamide on active force development is illustrated in Figure 2 . Increments in force de velopment with digoxin after exposure to both conceritrations of procainamide were not significantl y different statistically from that produced with digoxin alone. Pretreatment with 4 x 10 -7M digoxin also did not alter the positive inotropic response to procainarnide (Table I ).
Discussion
Comparison with previous studies. Our observation that procainamide exerted a positive inotropic effect over a wide range of concentrations is at variance with other studies that have reported that procainamide has a negative (2, 7) or no (3,9) effect on myocardial mechanical performance . However, others (6, 8) reached conlcusions similar to ours.
A number of factors, such as the use of atrial versus ventricular myocardium, intact anesthetized versus unanesthetized animals and human subjects, in vivo versus in vitro studies as well as species differences may contribute to these disparate results. Clearl y, the use of different conc entrations of procainamide is an important variable and high concentrations of the drug do produce negative inotropic effect s as we observed in several muscles expo sed to
Effect of basal contractile state on procainamide inotropism. An additional factor that we believe contributes to the variable response to procainamide is the level of mechanical performance before drug exposure. When we doubled the calcium concentration of our bathing solution, active force development increased by approximately 130% and procainamide then produced no significant increment in force. Increasing force development by increasing stimulus frequency also resulted in no inotropic response to procainamide. In muscles operating at increased levels of contractile state, the inotropic action of procainamide may not be apparent. However, there are exceptions as will now be discussed, Digoxin-procainamide interaction. Our results with a near maximal concentration of digoxin and procainamide demonstrate that neither drug alters the inotropic action of the other. This implies that their inotropism is mediated by different mechanisms. The latter implication is supported by studies that demonstrated that procainamide does not alter membrane sodium-potassium-adenosine triphophatase (ATPase) activity (11), inhibition of which is believed to result in the inotropic action of digitalis (12, 13) .
Mechanism of procainamide effects. The normal inotropic response to procainamide after the contractile state was increased by digoxin is unlike the blunted effect of procainamide after increasing the contractile state by increasing extracellular calcium or more rapid rates of stimulation. The lack of inotropic effect of procainamide under these Iarterconditions suggests a similar mechanism of inotropic action, Increased extracellular calcium increases intracellular calcium by directly enhancing slow channel influx, The mechanism of action responsible for the forcefrequency effect is less clear, although increased slow channel influx may be involved (14) , Our observations with propranolol indicate that procainamide exerts at least part of its inotropic effect by stimulation of beta-adrenergic receptors either directly or indirectly. OUf results with verapamil are compatible with either a direct effect of procainamide on slow channel influx or a betaadrenergic receptor agonist action. Others (15) demonstrated that beta-adrenergic receptor stimulation augments slow channel influx of calcium and that this effect and its accompanying increase in force development can be blocked by calcium antagonists. An argument against the concept that procainamide stimulates beta-adrenergic receptors is the observation that concentrations of procainamide similar to those we employed did not increase tissue cyclic adenosine monophosphate (AMP) levels (16) . However, these studies were performed in atrial tissue.
Clinical implications. This study and our previous study (1) indicate that procainamide possesses distinct advantages over quinidine, but the clinical significance of these observations is conjectural. The concentrations of procainamide used in the digoxin studies (4 and 8 j.Lg/ml) are well within the therapeutic range for human beings and these concentrations did exert a positive inotropic effect albeit under unphysiologic conditions, However, procainamide has hemodynamic effects other than those due to its direct myocardial action, and the former may modify the cardiac response to the drug in vivo. Our study also was done using normal muscles, and the response of depressed myocardium may no! be similar. Furthermore, N-acetylprocainamide is a major metabolite of procainamide and has significantly different hemodynamic effects from those of its parent compound (17, 18) , In any event, we have demonstrated that drugs grouped together as class I antiarrhythmic agents on the basis of their electrophysiologic effects have strikingly different effects on mechanical performance and interact differently with the cardiac glycosides.
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